Colonization resistance against multi-drug-resistant bacteria: a narrative review

Colonization resistance by gut microbiota is a fundamental phenomenon in infection prevention and control. Hospitalized patients may be exposed to multi-drug-resistant bacteria when hand hygiene compliance among healthcare workers is not adequate. An additional layer of defence is provided by the he...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of hospital infection 2021-12, Vol.118, p.48-58
Hauptverfasser: Le Guern, R., Stabler, S., Gosset, P., Pichavant, M., Grandjean, T., Faure, E., Karaca, Y., Faure, K., Kipnis, E., Dessein, R.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 58
container_issue
container_start_page 48
container_title The Journal of hospital infection
container_volume 118
creator Le Guern, R.
Stabler, S.
Gosset, P.
Pichavant, M.
Grandjean, T.
Faure, E.
Karaca, Y.
Faure, K.
Kipnis, E.
Dessein, R.
description Colonization resistance by gut microbiota is a fundamental phenomenon in infection prevention and control. Hospitalized patients may be exposed to multi-drug-resistant bacteria when hand hygiene compliance among healthcare workers is not adequate. An additional layer of defence is provided by the healthy gut microbiota, which helps clear the exogenous bacteria and acts as a safety net when hand hygiene procedures are not followed. This narrative review focuses on the role of the gut microbiota in colonization resistance against multi-drug-resistant bacteria, and its implications for infection control. The review discusses the underlying mechanisms of colonization resistance (direct or indirect), the concept of resilience of the gut microbiota, the link between the antimicrobial spectrum and gut dysbiosis, and possible therapeutic strategies. Antimicrobial stewardship is crucial to maximize the effects of colonization resistance. Avoiding unnecessary antimicrobial therapy, shortening the antimicrobial duration as much as possible, and favouring antibiotics with low anti-anaerobe activity may decrease the acquisition and expansion of multi-drug-resistant bacteria. Even after antimicrobial therapy, the resilience of the gut microbiota often occurs spontaneously. Spontaneous resilience explains the existence of a window of opportunity for colonization of multi-drug-resistant bacteria during or just after antimicrobial therapy. Strategies favouring resilience of the gut microbiota, such as high-fibre diets or precision probiotics, should be evaluated.
doi_str_mv 10.1016/j.jhin.2021.09.001
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2570374350</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0195670121003145</els_id><sourcerecordid>2570374350</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-23896505a4d52c58873929d7b669dc9b0fdec2f56c5b2cde13843727b4f927903</originalsourceid><addsrcrecordid>eNp9kE1LAzEQhoMotlb_gAfZo5ddJ8lmdyNepPgFBRH0HLJJtqbsR02yFf31prR69DQw87wvzIPQOYYMAy6uVtnq3fYZAYIz4BkAPkBTzChJCaf8EE0Bc5YWJeAJOvF-BQBxz47RhOY5JxTyKXqZD-3Q228Z7NAnznjrg-yVSeRS2t6HpBvbYFPtxmX6ew1JLVUwzsrrRCa9dC6mNyamN9Z8nqKjRrbenO3nDL3d373OH9PF88PT_HaRKsqKkBJa8YIBk7lmRLGqKiknXJd1UXCteA2NNoo0rFCsJkobTKuclqSs84aTkgOdoctd79oNH6PxQXTWK9O2sjfD6AVhJdAyp2yLkh2q3OC9M41YO9tJ9yUwiK1KsRJblWKrUgAXUWUMXez7x7oz-i_y6y4CNzvAxC_j5054ZU10p60zKgg92P_6fwC4VoU4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2570374350</pqid></control><display><type>article</type><title>Colonization resistance against multi-drug-resistant bacteria: a narrative review</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Le Guern, R. ; Stabler, S. ; Gosset, P. ; Pichavant, M. ; Grandjean, T. ; Faure, E. ; Karaca, Y. ; Faure, K. ; Kipnis, E. ; Dessein, R.</creator><creatorcontrib>Le Guern, R. ; Stabler, S. ; Gosset, P. ; Pichavant, M. ; Grandjean, T. ; Faure, E. ; Karaca, Y. ; Faure, K. ; Kipnis, E. ; Dessein, R.</creatorcontrib><description>Colonization resistance by gut microbiota is a fundamental phenomenon in infection prevention and control. Hospitalized patients may be exposed to multi-drug-resistant bacteria when hand hygiene compliance among healthcare workers is not adequate. An additional layer of defence is provided by the healthy gut microbiota, which helps clear the exogenous bacteria and acts as a safety net when hand hygiene procedures are not followed. This narrative review focuses on the role of the gut microbiota in colonization resistance against multi-drug-resistant bacteria, and its implications for infection control. The review discusses the underlying mechanisms of colonization resistance (direct or indirect), the concept of resilience of the gut microbiota, the link between the antimicrobial spectrum and gut dysbiosis, and possible therapeutic strategies. Antimicrobial stewardship is crucial to maximize the effects of colonization resistance. Avoiding unnecessary antimicrobial therapy, shortening the antimicrobial duration as much as possible, and favouring antibiotics with low anti-anaerobe activity may decrease the acquisition and expansion of multi-drug-resistant bacteria. Even after antimicrobial therapy, the resilience of the gut microbiota often occurs spontaneously. Spontaneous resilience explains the existence of a window of opportunity for colonization of multi-drug-resistant bacteria during or just after antimicrobial therapy. Strategies favouring resilience of the gut microbiota, such as high-fibre diets or precision probiotics, should be evaluated.</description><identifier>ISSN: 0195-6701</identifier><identifier>EISSN: 1532-2939</identifier><identifier>DOI: 10.1016/j.jhin.2021.09.001</identifier><identifier>PMID: 34492304</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Anti-Bacterial Agents - pharmacology ; Anti-Bacterial Agents - therapeutic use ; Carbapenemase-producing Enterobacterales ; Cross-infection ; Drug Resistance, Multiple, Bacterial ; Dysbiosis ; Extended-spectrum beta-lactamase ; Gastrointestinal Microbiome ; Humans ; Klebsiella pneumoniae ; Microbiota ; Pharmaceutical Preparations ; Vancomycin-resistant enterococci</subject><ispartof>The Journal of hospital infection, 2021-12, Vol.118, p.48-58</ispartof><rights>2021 The Healthcare Infection Society</rights><rights>Copyright © 2021 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c356t-23896505a4d52c58873929d7b669dc9b0fdec2f56c5b2cde13843727b4f927903</citedby><cites>FETCH-LOGICAL-c356t-23896505a4d52c58873929d7b669dc9b0fdec2f56c5b2cde13843727b4f927903</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jhin.2021.09.001$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34492304$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Le Guern, R.</creatorcontrib><creatorcontrib>Stabler, S.</creatorcontrib><creatorcontrib>Gosset, P.</creatorcontrib><creatorcontrib>Pichavant, M.</creatorcontrib><creatorcontrib>Grandjean, T.</creatorcontrib><creatorcontrib>Faure, E.</creatorcontrib><creatorcontrib>Karaca, Y.</creatorcontrib><creatorcontrib>Faure, K.</creatorcontrib><creatorcontrib>Kipnis, E.</creatorcontrib><creatorcontrib>Dessein, R.</creatorcontrib><title>Colonization resistance against multi-drug-resistant bacteria: a narrative review</title><title>The Journal of hospital infection</title><addtitle>J Hosp Infect</addtitle><description>Colonization resistance by gut microbiota is a fundamental phenomenon in infection prevention and control. Hospitalized patients may be exposed to multi-drug-resistant bacteria when hand hygiene compliance among healthcare workers is not adequate. An additional layer of defence is provided by the healthy gut microbiota, which helps clear the exogenous bacteria and acts as a safety net when hand hygiene procedures are not followed. This narrative review focuses on the role of the gut microbiota in colonization resistance against multi-drug-resistant bacteria, and its implications for infection control. The review discusses the underlying mechanisms of colonization resistance (direct or indirect), the concept of resilience of the gut microbiota, the link between the antimicrobial spectrum and gut dysbiosis, and possible therapeutic strategies. Antimicrobial stewardship is crucial to maximize the effects of colonization resistance. Avoiding unnecessary antimicrobial therapy, shortening the antimicrobial duration as much as possible, and favouring antibiotics with low anti-anaerobe activity may decrease the acquisition and expansion of multi-drug-resistant bacteria. Even after antimicrobial therapy, the resilience of the gut microbiota often occurs spontaneously. Spontaneous resilience explains the existence of a window of opportunity for colonization of multi-drug-resistant bacteria during or just after antimicrobial therapy. Strategies favouring resilience of the gut microbiota, such as high-fibre diets or precision probiotics, should be evaluated.</description><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Carbapenemase-producing Enterobacterales</subject><subject>Cross-infection</subject><subject>Drug Resistance, Multiple, Bacterial</subject><subject>Dysbiosis</subject><subject>Extended-spectrum beta-lactamase</subject><subject>Gastrointestinal Microbiome</subject><subject>Humans</subject><subject>Klebsiella pneumoniae</subject><subject>Microbiota</subject><subject>Pharmaceutical Preparations</subject><subject>Vancomycin-resistant enterococci</subject><issn>0195-6701</issn><issn>1532-2939</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1LAzEQhoMotlb_gAfZo5ddJ8lmdyNepPgFBRH0HLJJtqbsR02yFf31prR69DQw87wvzIPQOYYMAy6uVtnq3fYZAYIz4BkAPkBTzChJCaf8EE0Bc5YWJeAJOvF-BQBxz47RhOY5JxTyKXqZD-3Q228Z7NAnznjrg-yVSeRS2t6HpBvbYFPtxmX6ew1JLVUwzsrrRCa9dC6mNyamN9Z8nqKjRrbenO3nDL3d373OH9PF88PT_HaRKsqKkBJa8YIBk7lmRLGqKiknXJd1UXCteA2NNoo0rFCsJkobTKuclqSs84aTkgOdoctd79oNH6PxQXTWK9O2sjfD6AVhJdAyp2yLkh2q3OC9M41YO9tJ9yUwiK1KsRJblWKrUgAXUWUMXez7x7oz-i_y6y4CNzvAxC_j5054ZU10p60zKgg92P_6fwC4VoU4</recordid><startdate>202112</startdate><enddate>202112</enddate><creator>Le Guern, R.</creator><creator>Stabler, S.</creator><creator>Gosset, P.</creator><creator>Pichavant, M.</creator><creator>Grandjean, T.</creator><creator>Faure, E.</creator><creator>Karaca, Y.</creator><creator>Faure, K.</creator><creator>Kipnis, E.</creator><creator>Dessein, R.</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202112</creationdate><title>Colonization resistance against multi-drug-resistant bacteria: a narrative review</title><author>Le Guern, R. ; Stabler, S. ; Gosset, P. ; Pichavant, M. ; Grandjean, T. ; Faure, E. ; Karaca, Y. ; Faure, K. ; Kipnis, E. ; Dessein, R.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-23896505a4d52c58873929d7b669dc9b0fdec2f56c5b2cde13843727b4f927903</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Carbapenemase-producing Enterobacterales</topic><topic>Cross-infection</topic><topic>Drug Resistance, Multiple, Bacterial</topic><topic>Dysbiosis</topic><topic>Extended-spectrum beta-lactamase</topic><topic>Gastrointestinal Microbiome</topic><topic>Humans</topic><topic>Klebsiella pneumoniae</topic><topic>Microbiota</topic><topic>Pharmaceutical Preparations</topic><topic>Vancomycin-resistant enterococci</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Le Guern, R.</creatorcontrib><creatorcontrib>Stabler, S.</creatorcontrib><creatorcontrib>Gosset, P.</creatorcontrib><creatorcontrib>Pichavant, M.</creatorcontrib><creatorcontrib>Grandjean, T.</creatorcontrib><creatorcontrib>Faure, E.</creatorcontrib><creatorcontrib>Karaca, Y.</creatorcontrib><creatorcontrib>Faure, K.</creatorcontrib><creatorcontrib>Kipnis, E.</creatorcontrib><creatorcontrib>Dessein, R.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of hospital infection</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Le Guern, R.</au><au>Stabler, S.</au><au>Gosset, P.</au><au>Pichavant, M.</au><au>Grandjean, T.</au><au>Faure, E.</au><au>Karaca, Y.</au><au>Faure, K.</au><au>Kipnis, E.</au><au>Dessein, R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Colonization resistance against multi-drug-resistant bacteria: a narrative review</atitle><jtitle>The Journal of hospital infection</jtitle><addtitle>J Hosp Infect</addtitle><date>2021-12</date><risdate>2021</risdate><volume>118</volume><spage>48</spage><epage>58</epage><pages>48-58</pages><issn>0195-6701</issn><eissn>1532-2939</eissn><abstract>Colonization resistance by gut microbiota is a fundamental phenomenon in infection prevention and control. Hospitalized patients may be exposed to multi-drug-resistant bacteria when hand hygiene compliance among healthcare workers is not adequate. An additional layer of defence is provided by the healthy gut microbiota, which helps clear the exogenous bacteria and acts as a safety net when hand hygiene procedures are not followed. This narrative review focuses on the role of the gut microbiota in colonization resistance against multi-drug-resistant bacteria, and its implications for infection control. The review discusses the underlying mechanisms of colonization resistance (direct or indirect), the concept of resilience of the gut microbiota, the link between the antimicrobial spectrum and gut dysbiosis, and possible therapeutic strategies. Antimicrobial stewardship is crucial to maximize the effects of colonization resistance. Avoiding unnecessary antimicrobial therapy, shortening the antimicrobial duration as much as possible, and favouring antibiotics with low anti-anaerobe activity may decrease the acquisition and expansion of multi-drug-resistant bacteria. Even after antimicrobial therapy, the resilience of the gut microbiota often occurs spontaneously. Spontaneous resilience explains the existence of a window of opportunity for colonization of multi-drug-resistant bacteria during or just after antimicrobial therapy. Strategies favouring resilience of the gut microbiota, such as high-fibre diets or precision probiotics, should be evaluated.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>34492304</pmid><doi>10.1016/j.jhin.2021.09.001</doi><tpages>11</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0195-6701
ispartof The Journal of hospital infection, 2021-12, Vol.118, p.48-58
issn 0195-6701
1532-2939
language eng
recordid cdi_proquest_miscellaneous_2570374350
source MEDLINE; ScienceDirect Journals (5 years ago - present)
subjects Anti-Bacterial Agents - pharmacology
Anti-Bacterial Agents - therapeutic use
Carbapenemase-producing Enterobacterales
Cross-infection
Drug Resistance, Multiple, Bacterial
Dysbiosis
Extended-spectrum beta-lactamase
Gastrointestinal Microbiome
Humans
Klebsiella pneumoniae
Microbiota
Pharmaceutical Preparations
Vancomycin-resistant enterococci
title Colonization resistance against multi-drug-resistant bacteria: a narrative review
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T05%3A01%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Colonization%20resistance%20against%20multi-drug-resistant%20bacteria:%20a%20narrative%20review&rft.jtitle=The%20Journal%20of%20hospital%20infection&rft.au=Le%20Guern,%20R.&rft.date=2021-12&rft.volume=118&rft.spage=48&rft.epage=58&rft.pages=48-58&rft.issn=0195-6701&rft.eissn=1532-2939&rft_id=info:doi/10.1016/j.jhin.2021.09.001&rft_dat=%3Cproquest_cross%3E2570374350%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2570374350&rft_id=info:pmid/34492304&rft_els_id=S0195670121003145&rfr_iscdi=true